Synthetic Biologist Aims to Create Pig with Human Lungs
By Lisa M. Krieger,
San Jose Mercury News
| 11. 14. 2014
Untitled Document
SAN FRANCISCO -- In a provocative cross-species experiment, scientists are striving to rewrite the pig genome so the animal grows lungs that could be transplanted into humans.
"We are re-engineering the pig, changing its genetic code," said genome pioneer Craig Venter at SynBioBeta 2014, an annual synthetic biology conference in San Francisco. "If we succeed with rewriting the pig genome, we will have replacement organs for those who need them," he said Friday.
His team at Synthetic Genomics is designing the project, he said, creating on computers the code needed to build the hybrid. By changing as few as five genes, they have created lungs that survived for a year in baboons, he said.
In other major news at the conference, Google confirmed that Stanford University bioengineer Drew Endy has joined its team at the secretive Google X, which created such projects as Google Glass, driverless cars and high-altitude Wi-Fi balloons.
The hiring of Endy, brought to Stanford's School of Engineering from the Massachusetts Institute of Technology, suggests that Google seeks to explore the design and construction of...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
